|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wilson Kevin S. |
CEO and President |
|
2016-06-02 |
4 |
S |
$36.49 |
$734,800 |
D/D |
(20,000) |
180,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-31 |
4 |
A |
$36.88 |
$5,116,842 |
I/I |
138,743 |
138,743 |
|
- |
|
Gordon G Irwin |
Director |
|
2016-05-12 |
4 |
OE |
$11.00 |
$48,094 |
D/D |
4,372 |
17,876 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-12 |
4 |
S |
$38.50 |
$192,500 |
D/D |
(5,000) |
200,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-10 |
4 |
S |
$36.50 |
$551,250 |
D/D |
(15,000) |
205,000 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-05-10 |
4 |
S |
$36.87 |
$184,365 |
D/D |
(5,000) |
4,500 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-05-10 |
4 |
OE |
$11.47 |
$57,350 |
D/D |
5,000 |
9,500 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-05-10 |
4 |
S |
$36.50 |
$218,927 |
D/D |
(5,998) |
30,167 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-05-10 |
4 |
OE |
$7.36 |
$91,334 |
D/D |
5,998 |
33,971 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-09 |
4/A |
S |
$35.60 |
$310,361 |
D/D |
(8,718) |
220,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-09 |
4 |
S |
$35.60 |
$345,961 |
D/D |
(9,718) |
219,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-05-05 |
4 |
S |
$35.67 |
$45,728 |
D/D |
(1,282) |
228,718 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-05-05 |
4 |
S |
$35.66 |
$534,863 |
D/D |
(15,000) |
4,500 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-05-05 |
4 |
OE |
$8.34 |
$152,420 |
D/D |
15,000 |
9,500 |
|
- |
|
Napolitano Jason A |
COO, CFO, EVP and Secretary |
|
2016-05-03 |
4 |
AS |
$35.75 |
$178,750 |
D/D |
(5,000) |
63,544 |
|
- |
|
Napolitano Jason A |
COO, CFO, EVP and Secretary |
|
2016-04-25 |
4 |
OE |
$4.40 |
$4,400 |
D/D |
1,000 |
68,544 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-03-08 |
4 |
B |
$32.49 |
$32,490 |
D/D |
1,000 |
5,500 |
2.39 |
- |
|
Wisnewski Nancy |
EVP, Prod. Dev. & Cust. Supp |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,946 |
33,735 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2016-03-02 |
4 |
D |
$33.64 |
$35,322 |
D/D |
(1,050) |
7,814 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,881 |
8,864 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-03-02 |
4 |
D |
$33.64 |
$35,255 |
D/D |
(1,048) |
7,816 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,881 |
8,864 |
|
- |
|
Eyl Steven M. |
EVP, Commercial Operations |
|
2016-03-02 |
4 |
D |
$33.64 |
$31,252 |
D/D |
(929) |
8,807 |
|
- |
|
Eyl Steven M. |
EVP, Commercial Operations |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,985 |
9,736 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-03-02 |
4 |
D |
$33.64 |
$25,465 |
D/D |
(757) |
30,098 |
|
- |
|
465 Records found
|
|
Page 15 of 19 |
|
|